Journal article

Examining the impact of regular aspirin use and PIK3CA mutations on survival in stage 2 colon cancer

Caitlin Murphy, Natalie Turner, Hui-Li Wong, Mathu Sinnathamby, Jeanne Tie, Belinda Lee, Jayesh Desai, Iain Skinner, Michael Christie, Ryan Hutchinson, Sebastian Lunke, Paul Waring, Peter Gibbs, Tran Ben

Internal Medicine Journal | WILEY | Published : 2017

DOI: 10.1111/imj.13312

Grants

Funding Acknowledgements

This project was funded by Western Health Oncology Research Unit.

Citation metrics

5Web of Science
6Scopus

Keywords

Phosphatidylinositol 3-Kinases
Female
Anti-Inflammatory Agents, Non-Steroidal
Prospective Studies
Systemic Inflammatory Response
Aged
Survival Analysis
Chemotherapy Improves Survival
Mutation
Aspirin
Hereditary Colorectal-Cancer
Pik3ca
Genetic Testing
Class I Phosphatidylinositol 3-Kinases
Australia
Real-World Data
Risk
American Joint Committee
Diagnosis
Science & Technology
Colon Cancer
Metaanalysis
Colorectal Cancer
Adjuvant Chemotherapy
High-Throughput Nucleotide Sequencing
Middle Aged
Curative Resection
Adult
Humans
Pik3ca
Male
Multivariate Analysis
Databases, Factual
Medicine, General & Internal
Aged, 80 and Over
Colonic Neoplasms
Therapy
Life Sciences & Biomedicine
General & Internal Medicine